Exhibit 99.3
In the preliminary prospectus supplement filed pursuant to Rule 424(b)(5) in connection with a public offering of common stock by OrthoPediatrics Corp. (the "Company"), the Company provided the following overview of the Company's business and the following risk factors as updates or supplements to the information provided in the Company's previous periodic filings with the Securities and Exchange Commission. Unless the context otherwise requires, references herein to "OrthoPediatrics," "the Company," "our company," "we," "us" and "our" refer to OrthoPediatrics Corp., together with its subsidiaries.